cisplatin 50 mg/50 ml soluţie perfuzabilă
monoos ltd - cisplatinum - soluţie perfuzabilă - 50 mg/50 ml
kisplyx
eisai gmbh - lenvatinib mesilate - carcinomul, celula renală - agenți antineoplazici - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.
cisplatin kocak 10 mg/20 ml
kocak farma ilac ve kimya sanayi a.s. - turcia - cisplatinum - conc. pt. sol. perf. - 10mg/20ml - alte antineoplazice compusi ai platinei
cisplatină accord 1 mg/ml concentrat pentru soluţie perfuzabilă
accord healthcare polska sp. z.o.o - cisplatinum - concentrat pentru soluţie perfuzabilă - 1 mg/ml
rispolux 0,5 mg
hexal ag - germania - risperidonum - film orodispersabil - 0,5mg - neuroleptice (antipsihotice) alte antipsihotice
rispolux 1 mg
hexal ag - germania - risperidonum - film orodispersabil - 1mg - neuroleptice (antipsihotice) alte antipsihotice
rispolux 2 mg
hexal ag - germania - risperidonum - film orodispersabil - 2mg - neuroleptice (antipsihotice) alte antipsihotice
rispolux 3 mg
hexal ag - germania - risperidonum - film orodispersabil - 3mg - neuroleptice (antipsihotice) alte antipsihotice
platosin 0,5 mg/ml
pharmachemie b.v. - olanda - cisplatinum - conc. pt. sol. perf. - 0,5 mg/ml - alte antineoplazice compusi ai platinei
platosin 1 mg/ml
pharmachemie b.v. - olanda - cisplatinum - conc. pt. sol. perf. - 1 mg/ml - alte antineoplazice compusi ai platinei